Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-026451

Options or other derivatives

  • Chief Regulatory Officer acquired 117,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Puri Raj K. Chief Regulatory Officer 2026-03-09 Grant or award · Restricted Stock Units +117,500 117,500 D
Loading xslF345X05/tm268453-4_4seq1.xml…